Altimmune, Inc. (ALT) Operating margin 2016–2025
Altimmune, Inc. (ALT) operating margin by fiscal year — reported operating income divided by reported revenue.
-230461.0%FY2025 · since FY2016: -342.7% → -230461.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -230461.0% | +285399.0 pp |
| FY2024 | -515860.0% | -493341.5 pp |
| FY2023 | -22518.5% | — |
| FY2021 | -2197.4% | -1527.9 pp |
| FY2020 | -669.5% | -299.5 pp |
| FY2019 | -370.0% | +44.6 pp |
| FY2018 | -414.6% | +70.1 pp |
| FY2017 | -484.7% | -141.9 pp |
| FY2016 | -342.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice